JAK2 and breast cancer: Lnc-BM increased Janus kinase-2 (JAK2) kinase activity to trigger STAT 3 phosphorylation, followed by macrophage recruitment and activation, thus promoting BCBMs by mediating communication between BC cells and the brain microenvironment.